Barry, OppHub America Desk · · Source: prnewswire-all
IVD Raw Material Market to Hit $31.1B by 2031
The raw material market's projected growth signals potential opportunities within the broader healthcare and biotechnology sectors.
Based on reporting from prnewswire-all.
The in vitro diagnostic (IVD) raw material market is expected to reach $31.1 billion by 2031, growing at a compound annual growth rate of 7.7% from $21.5 billion in 2026. This expansion is driven by increasing disease prevalence and the demand for accurate diagnostics.
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
**Implied Volatility / Movement:** NORMAL
The global in vitro diagnostic (IVD) raw material market is poised for significant growth, projected to reach $31.1 billion by 2031 from $21.5 billion in 2026, according to a report by MarketsandMarkets™. This represents a compound annual growth rate of 7.7% during the forecast period.
Key market drivers include the rising incidence of chronic and infectious diseases, a growing need for early and precise disease diagnosis, and the increasing adoption of advanced diagnostic technologies such as molecular diagnostics and point-of-care testing. The report highlights that antibodies held a substantial market share of 34.5% in 2025, while in-house manufacturing dominated supply sources with a 66.1% share in the same year. Infectious disease testing accounted for the largest application segment at 25.5% in 2025.
### Catalyst Analysis: IVD Raw Material Market Expansion
### Technical Analysis & Key Risk Watch
### Impact on Healthcare Sector
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
The raw material market's projected growth signals potential opportuniti
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: August 15, 2026 at 12:31 AM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
diagnostics supply chain
The market for the basic ingredients used in medical tests is growing fast as more people need accurate disease detection. Investors care because this steady growth supports companies that supply medical testing tools.
What changed
A new industry forecast projects the global IVD raw material market to expand to $31.1 billion by 2031.
Who wins / who loses
Life science tool suppliers and diagnostics makers benefit from higher demand, while uncompetitive manufacturers could lose share.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $TMOBuild slowly — only if it fits your plan
A large company that provides supplies and tools for medical tests stands to gain as testing demand grows.
View $TMO chart → · End-of-day delayed data
- $DHRBuild slowly — only if it fits your plan
A major healthcare supplier that benefits directly when hospitals and labs need more testing ingredients.
View $DHR chart → · End-of-day delayed data
Peer
- $ABTWatch — track, don’t rush
A big healthcare company that makes medical tests and uses these raw materials.
View $ABT chart → · End-of-day delayed data
- $PKIWatch — track, don’t rush
A smaller player focused on diagnostics and lab testing equipment.
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Beginners should skip options here and stick to buying shares or ETFs if they want to invest in healthcare growth.
See options-friendly brokers →Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Research specialized contract development and manufacturing organizations (CDMOs) in biotech.
What would break this thesis
- A major slowdown in healthcare R&D spending or unexpected regulatory hurdles for diagnostic kits.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from prnewswire-all.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).